HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
about
Protective Effect of HLA-B*5701 and HLA-C -35 Genetic Variants in HIV-Positive Caucasians from Northern PolandGenerating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction dataStructural and regulatory diversity shape HLA-C protein expression levels.HLA-C -35kb expression SNP is associated with differential control of β-HPV infection in squamous cell carcinoma cases and controlsTranscriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans.Identification of a naturally processed HLA-Cw7-binding peptide that cross-reacts with HLA-A24-restricted ovarian cancer-specific CTLs.Correlation of Single Nucleotide Polymorphism 35-Kb Upstream of HLA-C and Clinical Profile of Multidrug-Resistant Tuberculosis.Zooming into the binding groove of HLA molecules: which positions and which substitutions change peptide binding most?High frequency of HIV mutations associated with HLA-C suggests enhanced HLA-C-restricted CTL selective pressure associated with an AIDS-protective polymorphismIncreased HLA-E expression in white matter lesions in multiple sclerosis.Allorecognition of HLA-C Mismatches by CD8+ T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities.Immunoprevalence and immunodominance of HLA-Cw*0801-restricted T cell response targeting the hepatitis B virus envelope transmembrane region.Maternal KIR and fetal HLA-C: a fine balance.The emerging role of HLA-C in HIV-1 infection.A novel post-transcriptional role for ubiquitin in the differential regulation of MHC class I allotypes.Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome.Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver?A comprehensive analysis of constitutive naturally processed and presented HLA-C*04:01 (Cw4)-specific peptides.A genome-wide association study in Caucasian women suggests the involvement of HLA genes in the severity of facial solar lentigines.Endoplasmic Reticulum Aminopeptidase 2, a common immunological link to adverse pregnancy outcomes and cancer clearance?HSV-2 specifically down regulates HLA-C expression to render HSV-2-infected DCs susceptible to NK cell killing.Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?HLA-C and KIR combined genotype as new response marker for HBeAg-positive chronic hepatitis B patients treated with interferon-based combination therapy.Genetic variants in five novel loci including CFB and CD40 predispose to chronic hepatitis B.A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.Comprehensive Analysis of Cytomegalovirus pp65 Antigen-Specific CD8+ T Cell Responses According to Human Leukocyte Antigen Class I Allotypes and Intraindividual Dominance.Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.Cytomegalovirus-Specific T Cells Restricted by HLA-Cw*0702 Increase Markedly with Age and Dominate the CD8+ T-Cell Repertoire in Older People.Decidual T Cells Exhibit a Highly Differentiated Phenotype and Demonstrate Potential Fetal Specificity and a Strong Transcriptional Response to IFN.The molecular basis for peptide repertoire selection in the human leucocyte antigen (HLA) C*06:02 molecule.Generalists and Specialists: A New View of How MHC Class I Molecules Fight Infectious Pathogens.
P2860
Q28548130-302D3660-A594-4A2C-A662-9A22E4471401Q33718785-2889E8E4-D424-4D4D-A613-B1BDC0DF320FQ33851012-9A2414F7-B5AC-449E-BB7A-B418BB6C1998Q33989195-5579C2A8-8593-4103-85E0-CCF61128722FQ34303377-E0467EF9-4ECC-426C-996B-7BDC74B3509EQ35717863-E4998FB6-4FFB-422D-AE4D-D880B5C9DC90Q35821055-5F88CAC7-CCA4-40E0-A8C4-D4562CA52BCEQ35837827-A66F0253-1DA3-407E-B62F-1A48BE0D6AB7Q36043743-201C0CD3-8715-4668-B5B9-0DEA3D6BB46FQ36488406-CC7D1E28-1A5C-43C5-9B87-D1D1547FB57EQ37494315-32784D68-248F-41E1-876B-14475E061680Q37547521-C4859084-D16F-4580-87A8-67AE28742F67Q37923237-2B3D38DD-6308-4F23-A361-3EE38C88BF01Q37927233-E185FB52-668D-415D-BD77-D12E1CD5D097Q38058915-D5B45074-7D18-4889-AA47-47A6FB660E34Q38214655-18B088ED-2AA6-4654-A3F5-D439C020EA19Q38270735-27BA8F69-D3B8-4CEA-9A9A-90092C771563Q39036828-EDBDEDDA-88E6-494A-BB6B-B6C2704DE8C1Q39162844-4BB6E5BF-5B93-4BA2-8875-6ADCC0C4A058Q39201032-9BB1ABE5-247C-4194-8F02-B8803DC6B636Q39385114-41A257C4-C88A-4CDC-B8DA-D1DDF56E55C6Q40048119-3863C183-D4B1-485F-8B26-0407E2D82F64Q40097257-EE74A89D-2C76-4E8C-AE79-E362EF213D36Q40766613-413FA785-9FB6-49B7-9395-C447849895DDQ42153005-88EB6A24-AE24-434F-99AD-51C6A604D986Q43882133-247416BB-C1CA-4A52-9542-F399B7E6FBF3Q47111092-EDC7323B-9BE9-4E51-AB3E-048F37C335DBQ47135573-DE5D3DE0-2D3A-40C8-8D3D-660018878C11Q47221262-47386889-E085-4938-80F4-F2E05B1E42E5Q47684869-594E1CAF-F15D-4110-80AE-97CD9CAC7BF0Q47881534-FE85CA9A-1436-45F8-8107-2400753ADB51Q48501373-8909EA96-B216-429A-9F65-922194CB0C6C
P2860
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@en
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@nl
type
label
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@en
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@nl
prefLabel
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@en
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@nl
P2093
P2860
P1433
P1476
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player?
@en
P2093
Marie-Eve Blais
Sarah Rowland-Jones
P2860
P356
10.1111/J.1365-2567.2011.03422.X
P577
2011-03-01T00:00:00Z